BIOHAVEN PHARMACEUTICAL

biohaven-pharmaceutical-logo

Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
#SimilarOrganizations #People #Financial #Website #More

BIOHAVEN PHARMACEUTICAL

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Health Diagnostics Neuroscience Pharmaceutical

Founded:
2013-01-01

Address:
New Haven, Connecticut, United States

Country:
United States

Website Url:
http://www.biohavenpharma.com

Total Employee:
1001+

Status:
Active

Total Funding:
443.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA Cloudflare JS CDN JS


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.


Current Advisors List

declan-doogan_image

Declan Doogan Chairman of the Board of Directors @ Biohaven Pharmaceutical
Board_member

julia-gregory_image

Julia Gregory Member Board Of Directors, Audit Committee Chair @ Biohaven Pharmaceutical
Board_member
2017-08-01

john-w-childs_image

John W. Childs Board o Directors @ Biohaven Pharmaceutical
Board_member

vlad-coric_image

Vlad Coric Board o Directors @ Biohaven Pharmaceutical
Board_member

Current Employees Featured

rob-berman_image

Rob Berman
Rob Berman Executive Officer & Co-Founder, Special Projects & Medical Oversight @ Biohaven Pharmaceutical
Executive Officer & Co-Founder, Special Projects & Medical Oversight
2019-01-01

james-engelhart_image

James Engelhart
James Engelhart Chief Financial Officer @ Biohaven Pharmaceutical
Chief Financial Officer
2016-05-01

charles-conway_image

Charles Conway
Charles Conway Chief Scientific Officer @ Biohaven Pharmaceutical
Chief Scientific Officer
2017-01-01

william-bj-jones_image

William "BJ" Jones
William "BJ" Jones Chief Commercial Officer, Migraine & Common Diseases @ Biohaven Pharmaceutical
Chief Commercial Officer, Migraine & Common Diseases
2019-04-01

vlad-coric_image

Vlad Coric
Vlad Coric Chief Executive Officer @ Biohaven Pharmaceutical
Chief Executive Officer
2015-10-01

azim-munivar_image

Azim Munivar
Azim Munivar Medical Director @ Biohaven Pharmaceutical
Medical Director

elyse-stock_image

Elyse Stock
Elyse Stock Chief Medical Officer @ Biohaven Pharmaceutical
Chief Medical Officer
2019-01-01

robert-croop_image

Robert Croop
Robert Croop Chief Development Officer, Neurology @ Biohaven Pharmaceutical
Chief Development Officer, Neurology
2017-01-01

john-tilton_image

John Tilton
John Tilton Chief Commercial Officer @ Biohaven Pharmaceutical
Chief Commercial Officer
2016-04-01

cliff-bechtold_image

Cliff Bechtold
Cliff Bechtold Chief Operating Officer @ Biohaven Pharmaceutical
Chief Operating Officer
2017-10-01

Founder


rob-berman_image

Rob Berman

Stock Details


Company's stock symbol is NYSE:BHVN

Acquisitions List

Date Company Article Price
2021-01-07 Kleo Kleo acquired by Biohaven Pharmaceutical 20 M USD

Investors List

soros-fund-management_image

Soros Fund Management

Soros Fund Management investment in Post-IPO Equity - Biohaven Pharmaceutical

venrock_image

Venrock

Venrock investment in Venture Round - Biohaven Pharmaceutical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Biohaven Pharmaceutical

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Venture Round - Biohaven Pharmaceutical

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Venture Round - Biohaven Pharmaceutical

aisling-capital_image

Aisling Capital

Aisling Capital investment in Venture Round - Biohaven Pharmaceutical

greg-bailey_image

Greg Bailey

Greg Bailey investment in Venture Round - Biohaven Pharmaceutical

knoll-capital-management_image

Knoll Capital Management

Knoll Capital Management investment in Venture Round - Biohaven Pharmaceutical

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Venture Round - Biohaven Pharmaceutical

litmore-capital_image

Litmore Capital

Litmore Capital investment in Venture Round - Biohaven Pharmaceutical

Investments List

Date Company Article Money raised
2021-03-01 Artizan Biosciences Biohaven Pharmaceutical investment in Series A - Artizan Biosciences 18.88 M USD
2018-11-14 Kleo Biohaven Pharmaceutical investment in Series B - Kleo 21 M USD
2016-09-01 Kleo Biohaven Pharmaceutical investment in Series A - Kleo N/A

Official Site Inspections

http://www.biohavenpharma.com Semrush global rank: 1.11 M Semrush visits lastest month: 29.03 K

  • Host name: ec2-3-130-137-99.us-east-2.compute.amazonaws.com
  • IP address: 3.130.137.99
  • Location: Columbus United States
  • Latitude: 39.9653
  • Longitude: -83.0235
  • Metro Code: 535
  • Timezone: America/New_York
  • Postal: 43215

Loading ...

More informations about "Biohaven Pharmaceutical" on Search Engine

dfkcompany.com © 2022. All rights reserved